SelectQuote, Inc. (SLQT) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Feb 5, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for SelectQuote, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, SelectQuote, Inc.'s filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-26.41%
from filing date
60-Day Change
-41.07%
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Continuing Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does SelectQuote, Inc. actually do?
Answer:
SelectQuote operates as a technology-enabled, direct-to-consumer platform for insurance and healthcare services, with a strategic focus on expanding its healthcare offerings. The company leverages AI and data science to optimize lead generation, routing, and sales processes, aiming to maximize the lifetime value of customer commissions. While its Senior segment, focused on Medicare Advantage and Supplement plans, remains a significant revenue driver, SelectQuote has de-emphasized its Auto & Home distribution business. The company's proprietary technology, combined with a skilled agent force, aims to provide consumers with transparent, personalized solutions and a superior customer experience. SelectQuote's business model is centered on earning commissions from insurance carrier partners, without bearing underwriting risk.
Question:
What are SelectQuote, Inc.'s revenue drivers?
Answer:
SelectQuote's primary revenue streams are commissions earned from insurance carrier partners for policies sold across its Senior, Life, and Auto & Home segments, and revenue generated from its pharmacy operations (SelectRx). Commissions include first-year and renewal commissions, as well as production bonuses and marketing development funds.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required